Terukatsu Arima

Title: Terukatsu Arima: Innovator in Hepatitis Diagnostics

Introduction

Terukatsu Arima is a notable inventor based in Kagoshima, Japan. He has made significant contributions to the field of hepatitis diagnostics, holding three patents that reflect his innovative work. His research focuses on developing assays for diagnosing non-A non-B hepatitis, which is crucial for improving patient outcomes.

Latest Patents

Arima's latest patents include an assay for non-A non-B hepatitis, which utilizes novel peptide fragments derived from polypeptide antigens. These assays are designed to diagnose NANBH by deleting portions of the polypeptide that contribute to high backgrounds, resulting in a high signal-to-background ratio. Another significant patent involves a novel cDNA clone, 20E, which encodes a previously unknown polypeptide antigen recognized by antibodies in the serum of certain patients with NANBH. This discovery suggests that the RNA sequence corresponding to clone 20E may represent an additional etiologic agent contributing to the development of NANBH in human patients.

Career Highlights

Throughout his career, Terukatsu Arima has worked with prominent companies such as Dade International Inc. and Akzo N.V. His experience in these organizations has allowed him to advance his research and contribute to the field of hepatitis diagnostics significantly.

Collaborations

Arima has collaborated with notable professionals in his field, including Winand J Habets and Pieter Jacob Boender. These collaborations have further enriched his research and innovation efforts.

Conclusion

Terukatsu Arima's work in hepatitis diagnostics exemplifies the impact of innovative research on public health. His patents and collaborations highlight his commitment to advancing medical science and improving diagnostic methods for non-A non-B hepatitis.